P570: REAL-WORLD EFFICACY OUTCOMES OF VENETOCLAX PLUS AZACITIDINE VS INTENSIVE CHEMOTHERAPY FOR INDUCTION THERAPY IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA מאת A. M. Zeidan, D. A. Pollyea, U. Borate, A. Vasconcelos, R. Potluri, D. Rotter, Z. Kiendrebeogo, L. Gaugler, G. Bonifacio, T. Prebet, C. Chen

קבל טקסט מלא

P519: TRANSFUSION INDEPENDENCE AMONG NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING VENETOCLAX-BASED COMBINATIONS VS OTHER THERAPIES: RESULTS FROM THE AML REAL WORLD EVI... מאת O. Wolach, J. S. Garcia, P. Vachhani, J. Zeidner, C. Lai, Y. Moshe, M. Xavier, S. Lee, T. Zuckerman, D. A. Pollyea, S. Abedin, E. C. Chen, S. Bathini, W. Edwards, C. N. Bui, W. W.-H. Cheng, A. Svensson, A. Guérin, J. Maitland, E. Ma, M. Montez, M. Grunspan, A. D. Goldberg

קבל טקסט מלא

S166: MAGROLIMAB IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH UNTREATED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR MDS): 5F9005 PHASE 1B STUDY RESULTS מאת D. A. Sallman, M. M. Al Malki, A. S. Asch, E. S. Wang, J. G. Jurcic, T. J. Bradley, I. W. Flinn, D. A. Pollyea, S. N. Kambhampati, T. N. Tanaka, J. F. Zeidner, G. Garcia-Manero, D. Jeyakumar, L. Gu, A. Tan, M. Chao, C. O’Hear, I. Lal, P. Vyas, N. Daver

קבל טקסט מלא